Free Trial
NASDAQ:NVACR

NorthView Acquisition (NVACR) Stock Price, News & Analysis

→ Bill Gates is all about this tiny $2 stock (From Timothy Sykes) (Ad)
Free NVACR Stock Alerts
$0.14
+0.02 (+15.61%)
(As of 05/10/2024)
Today's Range
$0.14
▼
$0.14
50-Day Range
$0.11
▼
$0.18
52-Week Range
$0.03
▼
$0.19
Volume
10,400 shs
Average Volume
35,660 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsOwnershipSEC FilingsShort InterestSocial Media

About NorthView Acquisition

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation operates as a subsidiary of NorthView Sponsor I, LLC.

NVACR Stock Price History

NVACR Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive NVACR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NorthView Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:NVACR
CUSIP
N/A
CIK
1859807
Web
www.northviewac.com
Phone
212-494-9022
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Jack E. Stover CPA (Age 71)
    Co-Founder, CEO & Director
  • Mr. Fred S. Knechtel (Age 63)
    Co-Founder, Executive VP, CFO & Director

NVACR Stock Analysis - Frequently Asked Questions

How have NVACR shares performed in 2024?

NorthView Acquisition's stock was trading at $0.0872 at the start of the year. Since then, NVACR stock has increased by 60.6% and is now trading at $0.14.
View the best growth stocks for 2024 here.

What ETF holds NorthView Acquisition's stock?

SPAC and New Issue ETF holds 26,370 shares of NVACR stock, representing 0.03% of its portfolio.

How do I buy shares of NorthView Acquisition?

Shares of NVACR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NVACR) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Does this make you sick?
Allegiance Gold
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Bill Gates is all about this tiny $2 stock
Timothy Sykes
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing